Stay updated on Pembrolizumab vs Chemotherapy in Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab vs Chemotherapy in Lung Cancer Clinical Trial page.

Latest updates to the Pembrolizumab vs Chemotherapy in Lung Cancer Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe page now shows Revision: v3.4.2 and no longer displays Revision: v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check20 days agoChange DetectedThe page shows a revision tag update from v3.4.0 to v3.4.1, with no changes to study details, endpoints, or eligibility criteria. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check27 days agoChange DetectedAdded a 'Show glossary' option and updated metadata fields: Last Update Submitted that Met QC Criteria, No FEAR Act Data, and Revision: v3.4.0. The previous labels and version (Last Update Submitted that met QC Criteria, No FEAR Act data, Revision: v3.3.4) were replaced.SummaryDifference0.2%

- Check42 days agoChange DetectedRevision: v3.3.4 replaces the previous v3.3.3 on the page. It appears to be a software/content management update rather than a modification to the study details.SummaryDifference0.0%

- Check63 days agoChange DetectedFooter shows Revision: v3.3.3; the HHS Vulnerability Disclosure link and the Revision: v3.3.2 notice have been removed.SummaryDifference0.1%

- Check92 days agoChange DetectedEditorial updates to the Publications section clarify publication sourcing, and the revision version was updated.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab vs Chemotherapy in Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs Chemotherapy in Lung Cancer Clinical Trial page.